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Background: Oxygen is designated an essential drug by the World 
Health Organisation, and reduces mortality in hypoxic patients. In 
low-resource settings the provision of oxygen seldom meets its 
demand. This study describes the predictors and observed time-
course of hypoxaemia in order to inform needs assessments for 
oxygen in hospitals in low and middle income countries. 
Methods: A prospective cohort study of adults with hypoxaemia 
admitted to medical wards of a teaching hospital in Malawi between 
January and March 2020. Vital signs and oxygen therapy were 
recorded daily. We analysed outcomes (death, discharge from hospital 
or ongoing inpatient care at 14 days after admission) using Kaplan-
Meier and Cox regression time-to-event analysis.  
Results: 33 patients were recruited with median age 45 years (IQR 33-
61), and 13 (39%) female. Median pre-treatment oxygen saturations 
were 84% (IQR 76-87%). Oxygen delivery devices were often shared 
with other patients (n=10, 33%) and the flow rate was often unknown 
(n=14, 47%), mostly because of broken equipment (n=8, 57%). 
Median duration of oxygen therapy was 3 days (IQR 1-7). Death 
occurred in 16 (49%). Hazard ratios for short oxygen therapy were 
reduced in patients who had a chest radiograph performed (HR 0.08, 
95% CI 0.02–0.30), in ex-smokers (HR 0.01, 95% CI 0.00-0.22) and in 
never smokers (HR 0.03, 95% CI 0.00 – 0.78). 
Conclusions: Delivering oxygen therapy in lower-middle income 
countries is challenging; broken equipment and shared delivery 
devices prevented titration of flow rates. Patients were relatively 
young and at a high risk of death. Patients with a chest radiograph 
received oxygen for longer than those without. Knowledge of oxygen 
therapy durations will allow careful assessment of the oxygen supply 
need at the hospital level.
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Introduction
Oxygen reduces morbidity and mortality in hypoxaemic 
patients, and is listed as an essential drug by the World Health 
Organisation (WHO) (Evans et al., 2016; World Health 
Organization, 2015c). If untreated, failure of oxygen supply to 
tissues precipitates organ failure and death (Duke et al., 2010b; 
Goldhill, 2001). Supplemental oxygen can prevent hypoxia, and 
in paediatric studies has reduced pneumonia mortality by 35% 
(Duke et al., 2008). However, supply in resource-limited set-
tings is frequently restricted by availability, equipment cost 
and maintenance difficulties (Enarson et al., 2008; Evans et al., 
2016; La Vincente et al., 2011). Prominent causes of hypoxae-
mia are lower respiratory tract infections, which cause 3 million 
annual deaths globally and 15,000 deaths in Malawi alone, 
which represent 9% of the national mortality, and are the 
most common cause of adult hospitalization (‘GBD 2015 LRI 
Collaborators’, 2017; SanJoaquin et al., 2013).
Previous studies in a regional hospital in Malawi (Queen 
Elizabeth Central Hospital, Blantyre; QECH) showed that 
less than one-third of patients that required supplemental oxy-
gen received it, highlighting the disparity between supply and 
demand (Evans et al., 2016). This prospective cohort study 
explored the observed time course of hypoxaemia and predic-
tors of supplemental oxygen therapy requirements in medical 
patients in Blantyre to inform needs assessment for oxygen 
at the hospital level.
Methods
Setting and study design
We conducted a prospective cohort study of adults with 
hypoxaemia at the QECH in Blantyre, Malawi, between 
18th February 2020 and 20th March 2020. The hospital has 
200 medical beds, providing healthcare to approximately 
1 million people in a context of high community prevalence of 
human immunodeficiency virus (HIV, 10.6%) and incidence of 
tuberculosis (159 cases per 100,000 population) (‘Government 
of Malawi’, 2015; World Health Organization, 2015a; World 
Health Organization, 2017).
Adults, aged 18 years and above, were included if they were 
hypoxaemic, were treated with supplemental oxygen and were 
admitted under the medical teams. Hypoxaemia was defined 
as peripheral oxygen saturations of less than 90% by finger 
pulse oximetry. Participants were recruited either from the 
emergency department, or from the medical wards if they 
were within 48 hours of admission. Written, informed consent 
was gained before any data collection was commenced. 
Those unwilling to consent to participation and those not 
receiving supplemental oxygen were excluded.
Data collection
Baseline demographics, admission details including vital signs 
and oxygen delivery method, diagnoses and co-morbidities 
were recorded on admission. Diagnoses made by the attending 
physician were extracted from medical notes. Haemoglobin 
and chest radiograph results were collected only if these were 
conducted as part of usual clinical care. Vital signs and details 
of supplemental oxygen delivery were recorded daily for 
participants until outcomes were determined (i.e. death, 
discharge, or ongoing inpatient care after 14 days). Oxygen sat-
urations were measured with oxygen therapy present and then 
with temporary removal of supplemental oxygen, providing it 
was clinically safe to do so. Data were collected using an Open 
Data Kit platform on tablet devices (www.kobotoolbox.org).
Statistical analysis
A sample size of 62 participants was calculated to power the 
study to estimate the duration of oxygen therapy with a 
precision 6 hours with a 95% confidence level, and a standard 
deviation of 24 hours. The primary outcome was the dura-
tion of oxygen therapy in days. Secondary outcomes were the 
availability and delivery of supplemental oxygen, length of 
hospital stay, factors associated with the duration of supplemental 
oxygen provision and clinical outcome.
Data were presented as means, standard deviations, medians, 
ranges or percentages, based on the type and distribution of 
data. Those experiencing other events (death, discharge) before 
the end of the study contributed to the proportional hazard 
until that event. The Kaplan-Meier method was used to assess 
time to event data and probabilities. Time to event in univari-
able analysis was estimated by log-rank test. Cox regression 
models were used for uni- and multi-variable analysis and to 
calculate hazard ratios. Competing risk of events were calcu-
lated using estimated cumulative incidence (Putter et al., 2007). 
Conditional survival analysis was used to predict chances of 
requiring oxygen therapy on given days (Zabor et al., 2013). 
Statistical significance was defined as p<0.05, and 95% confi-
dence intervals given where appropriate. Data were analysed 
using R (R Core Team, 2020).
Ethical considerations
Ethical approval was gained from the College of Medicine 
Research Ethics Committee, Blantyre, Malawi, (reference number 
P.05/19/2693) and the Liverpool School of Tropical Medi-
cine Research Ethics Committee, United Kingdom (reference 
number 19–088). All participants provided written informed 
consent prior to participating in the study.
Results
Baseline results
33 participants were recruited between 18th February 2020 
and 11th March 2020. Recruitment was stopped early due to 
coronavirus-19, and follow up discontinued on the 20th March 
2020. During this time 525 patients were admitted under the 
medical team at QECH.
Thirteen study participants were women (39.4%). The median 
age was 45 years (interquartile range (IQR) 33–61 years, 
Table 1). One third of participants were HIV positive, two were 
currently receiving treatment for tuberculosis (TB) and six 
had previously been treated for it. The most common present-
ing symptoms were dyspnoea and cough (n=18, 55% each). The 
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commonest admission diagnosis was pneumonia (n=14, 42%). 
14 participants had a chest radiograph (CXR) performed (42%), 
and haemoglobin level was measured in 20 participants, mean 
11.8g/dL (SD 2.6).
At initiation of oxygen therapy, median oxygen saturation was 
84% (IQR 76–87%), and median respiratory rate 28 breaths 
per minute (IQR 23–32). Most patients received oxygen therapy 
via nasal cannulae (n=23, 77%) supplied by a cylinder (n=22, 
73%). One oxygen source was shared with at least one other 
patient in 10 participants (33%). Median oxygen saturations after 
initiation of oxygen therapy were 98% (IQR 95–99%). Hypox-
aemia resolved in 30 participants (91%). Oxygen flow rate 
at time of initiation of therapy was often unknown due to 
broken equipment (n=14, 42%).
The median period of oxygen therapy was 3 days (IQR 1–7). 
The most frequent outcome was death (n=16, 48%), followed 
by discharged from hospital (n=9, 27%) and continued inpa-
tient at 14 days (n=5, 15%). 75% of deaths occurred by day 
3 of follow up (75%, Figure 1). Three participants were lost 
to follow-up (9%).
Table 1. Demographics and admission parameters of the 33 
included participants. Abbreviations as per main text. Results 
are number (%) unless otherwise indicated.
Variable Number 
(percentage)
Female sex, n (%) 13 (39.4 %)
Age, median (range) 45 (22 – 91)
Co-morbidities
  HIV, n (%) 11 (33 %)
  Receiving anti-retroviral therapy 9
  Previous TB treatment, n (%) 6 (18 %)
  Current TB treatment, n (%) 2 (6 %)
  Hypertension, n (%) 7 (21 %)
  Malignancy, n (%) 4 (12 %)
Smoking status
  Current, n (%) 2 (6 %)
  Ex, n (%) 9 (27 %)
  Never, n (%) 22 (67 %)
Presenting symptoms
  Dyspnoea, n (%) 18 (55 %)
  Cough, n (%) 18 (55 %)
  Fever, n (%) 15 (45 %)
  Productive cough, n (%) 12 (36 %)
  Orthopnoea, n (%) 11 (33 %)
  Headache, n (%) 10 (30 %)
  Chest pain, n (%) 10 (30 %)
Vital signs on admission
Heart rate, beats / min, median (IQR) 109 (89 – 123)
Respiratory rate, breaths / min, median (IQR) 28 (23 – 32)
Temperature, °C, median (IQR) 36.7 (36.1 
– 37.8)
SpO2 on air, %, median (IQR) 84 (76 - 87)
SpO2 with oxygen, %, median (IQR) 98 (95 – 99)
Method of supplemental oxygen on 
admission
Oxygen concentrator, n (%) 11 (33.4 %)
Oxygen cylinder, n (%) 22 (66.6 %)
Sharing device on admission, n (%) 10 (30.3 %)
Interface of oxygen delivery on admission
  Reservoir mask, n (%) 4 (12 %)
Variable Number 
(percentage)
  Simple mask, n (%) 6 (18 %)
  Nasal cannula, n (%) 23 (70 %)
Oxygen flow on admission, L/min, median 
(range)
6 (4-6)
Oxygen flow on admission unknown, n (%) 14 (42 %)
Chest radiograph performed, n (%) 14 (42 %)
Haemoglobin test performed, n (%) 20 (61 %)
Haemoglobin level, mg/dL, mean ± SD 11.8 ± 2.6
Length of stay, days, median (IQR) 6 (2 – 9.5)
Length of oxygen therapy, days, median 
(IQR)
3 (1 – 7)
Final diagnosis (can have multiple)
  Pneumonia, n (%) 14 (42 %)
  TB, n (%) 5 (15 %)
  Heart failure, n (%) 5 (15 %)
  Meningitis, n (%) 4 (12 %)
  Sepsis, n (%) 3 (9 %)
Outcome at end of study
  Death, n (%) 16 (48 %)
  Discharge before 14 days, n (%) 9 (27 %)
  Inpatient, n (%) 5 (15 %)
  Lost to follow up, n (%) 3 (9 %)
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Of a total of 167 cumulative follow up days, oxygen was given 
for 107 days (64%, Table 2). During this time, oxygen was 
usually supplied from cylinders (83%) and through nasal 
cannulae (83%). For most days one oxygen source was shared 
between at least two patients (71% of days). The median of 
peripheral saturations whilst receiving supplemental oxygen was 
93% (IQR 88–97%) compared to 91% (IQR 85–96%) without 
supplemental oxygen. The median of oxygen saturations was 
99% when supplemental oxygen was no longer required.
Duration of oxygen therapy
The use of oxygen declined by two-thirds between study 
commencement and day five of follow up, and then approxi-
mately halved from days 5 to 10 and from days 10 to 15 
(Figure 2). Two participants continued to receive supplemen-
tal oxygen up to day 15. The duration of therapy was associ-
ated with smoking status (p=0.03), the availability of a CXR 
(p<0.01), and the initial delivery device (p<0.01, Figure 3). In 
the univariable Cox regression analysis (Table 3), obtaining a 
chest radiograph had a reduced hazard ratio of still requiring 
oxygen on day 15 (HR 0.04, 95% CI 0.01–0.33, p< 0.01), i.e. an 
increased hazard of prolonged therapy. Requiring a reservoir 
mask on admission had an increased hazard of requiring sup-
plemental oxygen at the end of the study (HR 14.5, 95% 
CI 2.28–92.7, p <0.01). CXR, being an ex-smoker, or a never 
smoker remained significantly associated in multivariable analy-
sis (respective HR 0.08, 95%CI 0.02–0.30, p<0.01, HR 0.01, 
95%CI 0.00–0.22, p<0.01, and HR 0.03, 95%CI 0.00–0.78, 
p=0.03). There was a statistically non-significant trend to an 
association with age (HR 0.95,95% CI 0.89–1.00, p=0.05). The 
likelihood of receiving supplemental oxygen at the end of the 
study increased with prolonged oxygen therapy (Table 4).
Discussion
Despite oxygen therapy resolving hypoxaemia in most 
participants, mortality was almost 50% and three quarters of 
these deaths occurred in the first three days of admission, indi-
cating that hypoxaemia was a marker of severe and significant 
pathology. This recapitulates previous observations that hypox-
aemia is associated with increased 30-day mortality in adult 
patients with pneumonia (Aston et al., 2019).
In the absence of piped oxygen, it is recommended that oxygen 
concentrators are used when power supply is reliable (such as 
Figure 1. Competing interest graph of the probability of death (red), discharge (green) or inpatient without supplemental 
oxygen at study end (blue) by length of oxygen therapy (days). Calculated using cumulative incidence functions. Baseline comparison: 
inpatient on day 15 requiring supplemental oxygen therapy.
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Table 2. Description of oxygen delivery whilst on the medical wards by days of 
study. Results are total number (%), unless otherwise specified.
Variable Number (%)
Total days of follow up 167
      Total days that supplemental oxygen was given 107 (64 %)
      Total days that oxygen was not given 62 (36 %)
Peripheral oxygen saturations receiving supplemental oxygen, 
% (mode)
93
Peripheral oxygen saturations without supplemental oxygen 
(normally receiving supplemental oxygen), % (mode)
91
Oxygen saturations without supplemental oxygen (not normally 
receiving supplemental oxygen), % (mode)
99
Oxygen source used on the ward
  Cylinder, n (%) 89 (83 %)
  Concentrator, n (%) 18 (17 %)
Method of facial interface on the ward
  Nasal cannulae, n (%) 89 (83 %)
  Reservoir mask, n (%) 5 (5 %)
  Simple face mask, n (%) 13 (12 %)
Oxygen source and facial interface on the ward
Oxygen cylinder with 
  Nasal cannulae, n (%) 72 (81 %)
  Simple face mask, n (%) 13 (15 %)
  Reservoir mask, n (%) 4 (4 %)
Oxygen concentrator with
  Nasal cannulae, n (%) 17 (94 %)
  Reservoir mask, n (%) 1 (6 %)
Number of people connected to single oxygen source on the 
ward
  Only one person connected 31 (29 %)
  2 persons in total connected to same device 60 (56 %)
  3 persons in total connected to same device 16 (15 %)
Unable to record oxygen flow 91 (85 %)
Reason why oxygen flow could not be reported
  Dial broken 80 (88 %)
  Unknown 11 (12 %)
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in QECH) as they are comparatively cheap and provide consist-
ent oxygen (Duke et al., 2010a; World Health Organization, 
2015b). In our study, which immediately predates the intro-
duction of an on-site oxygen plant, oxygen cylinders were 
preferentially used. This may be due to the unavailability of 
concentrators or broken equipment, as has been described in pae-
diatric wards e.g. in Malawi and Mongolia (Evans et al., 2016; 
La Vincente et al., 2011). Equipment difficulties were evident 
in our study, notably broken flow meters, which meant titra-
tion was not possible for 91 of 107 follow up days. Sharing the 
oxygen source was also usual practice, making it difficult to 
titrate flow rates to the individual’s needs, and possibly result-
ing in wasting of oxygen resource. Moreover, over-oxygenation 
is associated with excess mortality, highlighting the need for 
good monitoring and the ability to control oxygen flow (Chu 
et al., 2018; Kane et al., 2013).
The median duration of supplemental oxygen therapy was 
three days, which was influenced by the large number of early 
deaths. Two participants required continuous, supplemental 
oxygen for more than two weeks. These observations could 
be used in planning oxygen services, and prioritizing the use 
of this finite resource. Previous research from QECH has 
highlighted that hypoxaemic patients often do not receive sup-
plemental oxygen, and similar findings have been recorded 
in other LMICs (Duke et al., 2010b; Evans et al., 2016).
Patients who were investigated with a CXR received oxygen 
for longer than those who had no radiography performed. A 
CXR may have allowed the identification of reversible pathol-
ogy and thus justified the medical decision to continue oxygen 
therapy. However, sicker patients with a higher oxygen require-
ment and poorer prognosis may have been less likely to 
have had a CXR initially, creating confounding bias.
Oxygen therapy duration was also statistically significantly 
associated with the initial delivery interface that was used. 
However, three out of the four participants who were using a 
reservoir mask died, two within two days of admission, indi-
cating sicker patients may have needed a reservoir mask. HIV 
status was not associated with oxygen therapy duration.
Figure 2. Kaplan-Meier curve of overall probability of receiving supplemental oxygen (%) and length of oxygen therapy (days). 
Censored data appear as crosses, grey area: 95 % confidence interval.
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Figure 3. Kaplan-Meier curves of probability of receiving supplemental oxygen and length of oxygen therapy (days) by a) smoking status, 
b) having a chest radiograph and c) initial device used to deliver oxygen. Censored data appears as crosses, grey area: 95% confidence 
interval.
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Table 3. Single and multi-variable hazard ratios (HR) by Cox regression analysis for not 
requiring supplemental oxygen at end of study. CI: confidence interval. * p < 0.05.
Variable Univariable HR 
95 % CI
p value Multivariable HR 
95 % CI
p value
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  Current 1.00
  Ex 0.08 
0.01 – 0.47
< 0.01* 0.01 
0.00 – 0.22
< 0.01*


























Peripheral oxygen saturations 











Interface used on admission
  Nasal canulae 1.00
  Reservoir mask 5.92 
1.75 – 20.1
< 0.01* 0.52 
0.04 – 6.53
0.6





Chest radiograph on admission 0.13 
0.05 – 0.37
< 0.01* 0.08 
0.02 – 0.30
< 0.01*
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Due to the global coronavirus-19 pandemic, planned recruit-
ment and follow up was curtailed, and our sample size was not 
reached. Despite high completeness of follow-up, this therefore 
limits the results of the regression analysis.
Conclusions
It has previously been demonstrated that programmatically 
introducing oxygen in paediatric populations is beneficial 
(Duke et al., 2008), however data from adult practice are few. 
Further research should outline how oxygen demand can be 
met in health centres that encounter hypoxaemic patients. 
Efficacy data are required to inform formal health economic 
analysis, but it is unlikely that these can be ethically determined. 
Instead, relative cost-efficiency estimates could help policymak-
ers in decisions to deploy oxygen solutions. Our data provide 
some patient-level data which describe periods of treatment, 




DataCat: Supplemental oxygen in Queen Elizabeth Central 
Hospital Malawi: a prospective cohort study of patients admitted 
to medical wards, http://dx.doi.org/10.17638/datacat.liverpool.
ac.uk/1211 (Stolbrink et al., 2021).
Data are available under the terms of the Creative Commons 
Attribution 4.0 International license (CC-BY 4.0).
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Table 4. Likelihood of requiring oxygen therapy at end 





Likelihood of requiring 
supplemental oxygen at 
end of study
95 % CI
1 0.12 0.02 – 0.31
2 0.16 0.03 – 0.39
3 0.21 0.04 – 0.48
5 0.27 0.05 – 0.56
7 0.38 0.05 – 0.74
10 0.67 0.02 – 0.96
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